Clinical outcomes of post-renal transplant patients with COVID-19 infection in the ICU: A single-center case series.

Nissar ShaikhMohamad Y KhatibMohammad A AlwraidatDore C AnanthegowdaMuftah OthmanAsra AroosSagar B JujjavarapuSaptarshi BanerjeeZishan NasirAhmed Soliman MohamedMoustafa S ElshafeiMuna A AlmaslamaniAbdulqadir Jeprel Nashwan

Published in: Clinical case reports (2021)

Most of the post-renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti-proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post-renal transplant patients with severe COVID-19 infection admitted to the intensive care unit.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
intensive care unit
prognostic factors
early onset
metabolic syndrome
patient reported outcomes